Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-23

Clinical Trial Update: Comprehensive Add on Study in Japan [Phase 3]

View source ↗

Summary

Phase 3 add-on study conducted in Japan for Type 2 diabetes has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-01-23